Ramón Hurtado

8 May 2025

Aspanoa invests 120.000 euros to promote new immunotherapies for childhood cancer.

It will be distributed equally between two research projects. One is led by Diego Sánchez (IIS Aragón) and the other by Eva Gálvez (CSIC) and Ramón Hurtado (BIFI – Unizar). Immunotherapy is a treatment already being applied to some cancer patients, including children, when standard therapies are insufficient.